← Back to Trial

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

Trial Locations

• Institut de Cancérologie de l'Ouest Angers, France
  • Contact: Elouen Boughalem, MD
• Institut Bergonié Bordeaux, France
  • Contact: Paul Schwartz, MD
• CHRU Brest Brest, France
  • Contact: Friederike Schlurmann, MD
• Centre Francois Baclesse Caen, France
  • Contact: Florence Joly, MD
• CHU Henri Mondor Créteil, France
  • Contact: Caroline Saldana, MD
• Centre Georges-François Leclerc Dijon, France
  • Contact: Clément Drouet, MD
• CHU Grenoble Grenoble, France
  • Contact: Loic Djaileb, MD
• Centre Léon Berard Lyon, France
  • Contact: Aude Flechon, MD
• Institut Paoli-Calmettes Marseille, France
  • Contact: Gwenaelle Gravis, MD
• CHRU Nancy Nancy, France
  • Contact: Pierre Olivier, MD
• Centre Antoine Lacassagne Nice, France
  • Contact: Delphine Borchiellini, MD
• Hôpital Cochin Paris, France
  • Contact: Olivier Hullard, MD
• Hôpital Saint Louis Paris, France
  • Contact: Hélène Gauthier
• Institut Curie Paris, France
  • Contact: Zahra Castel-Ajgal, MD
• Centre Eugène Marquis Rennes, France
  • Contact: Laurence Crouzet, MD
• Centre Henri Becquerel Rouen, France
  • Contact: David Tonnelet, MD
• CHU Rouen Rouen, France
  • Contact: Laetitia Augusto, MD
• Institut Curie Saint-Cloud, France
  • Contact: Capucine Richard, MD
• Institut de Cancérologie de l'Ouest Saint-Herblain, France
  • Contact: Emmanuelle Bompas, MD
• CHU Saint Etienne Saint-Priest-en-Jarez, France
  • Contact: Pierre Cornillon, MD
• ICANS Strasbourg, France
  • Contact: Philippe Barthelemy, MD
• IUCT Oncopole Toulouse, France
  • Contact: Loic Mourey, MD
• CHRU Tours Tours, France
  • Contact: Mathilde Cancel, MD
• Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy, France
  • Contact: Vincent MASSARD, MD
• Gustave Roussy Villejuif, France
  • Contact: Karim FIZAZI, MD